This study examined the relationship between deficits in color and con
trast discrimination and visual hallucinations (VH) in patients with P
arkinson's disease (PD) and normal visual acuity. Thirty-five nondemen
ted and nonpsychotic PD patients with normal visual acuity and without
major ophthalmologic disease were interviewed twice and divided into
two groups: hallucinators (n = 14) and non-hallucinating controls (n =
21). The groups were compared for color vision (assessed by Lanthony
D-15 [LD] and Farnsworth-Munsell 100 hue [FM] tests), and for contrast
sensitivity (tested by Vis tech tables [VT] and monocular and binocul
ar Pelli-Robson test [PR]). There was no difference in age, duration o
r stage of PD, or dosage or duration of levodopa therapy between the t
wo groups. Parkinson's disease patients showed impairment on all visua
l tests, with the hallucinators performing worse than the controls on
all tests. This difference was significant for the LD (p<0.007), the V
T at 1.5 and 3 cycles per degree (p<0.037 and 0.043, respectively) and
the monocular PR tests (p<0.049). The results led the authors to conc
lude that in patients with normal visual acuity, those with VH show ad
ded visual deficits of color and contrast discrimination. These ophtha
lmopathies may therefore be facilitating factors for visual hallucinat
ions in PD and justify more focused research on the pathophysiology of
visual hallucinations in Parkinson's disease.